Read More Pharma Industry News Corcept Therapeutics submits FDA application for relacorilant to treat Cushing’s syndrome Corcept Therapeutics Incorporated has taken a significant step in addressing the unmet needs of patients with hypercortisolism, commonly… byPallavi MadhirajuDecember 31, 2024